Patients and prescribers may still see intermittent localized supply disruptions as the products move through the supply chain from the manufacturer and distributors to local pharmacies
Concentration: 1% GHK-Cu (clinically validated range) Volume: 3mL, approximately 60 applications Price: $29.99 Format: Ready-to-use, no reconstitution Purity: 99%+ HPLC-verified with batch-specific COA Manufacturing: US-based, third-party tested PSPeptides also carries lyophilized GHK-Cu vials for researchers requiring the injectable format, plus two multi-peptide blends that include GHK-Cu: the GLOW Blend (BPC-157 + GHK-Cu + TB-500) and the KLOW Blend (adds KPV)
In-person office visits: $100- $200 per visit (typically monthly or biweekly)
In October, at the American College of Rheumatology Convergence 2025, interim Phase 1b results for SBT777101, an autologous CAR regulatory T-cell therapy, showed early signs of clinical activity and a favorable safety profile with no dose-limiting toxicities, cytokine release syndrome or immune effector cell-associated neurotoxicity syndrome
However, people with underlying conditions like a history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2 (MEN 2), or severe gastrointestinal disease should avoid semaglutide injections and consult medical professionals at a weight loss clinic for alternative options
